Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000935:Antifungal Agents / Q000378:metabolism*; D001792:Blood Platelets / Q000187:drug effects; D001835:Body Weight; D003404:Creatinine / Q000378:metabolism; D003596:Cytosine / Q000378:metabolism*; D005260:Female; D005437:Flucytosine / Q000032:analysis / Q000378:metabolism; D006207:Half-Life; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D007700:Kinetics; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000935:Antifungal Agents; D006454:Hemoglobins; D003596:Cytosine; D003404:Creatinine; D005437:Flucytosine; D000469:Alkaline Phosphatase